Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" ...

TAA-T cell therapy left four children with terminal brain cancer in long-term remission, with two new trials now expanding ...

An experimental immunotherapy has beaten aggressive brain tumours in a handful of children, and a personalised version is now ...

A cutting-edge immunotherapy could help kids fight — and even banish — brain tumors, the leading cause of cancer-related ...

Summary: Researchers demonstrated that the success of anti-CTLA-4 immunotherapy against brain tumors does not depend on local ...

A new experimental treatment may have found a way to outsmart glioblastoma’s toughest defense: the blood-brain barrier.

Several children who had aggressive recurrent brain tumors remained disease-free years after this treatment, according to an ...

Researchers have uncovered a clue to why immune checkpoint inhibitors-cancer therapies that release the immune "brakes" exploited by tumors to evade attack-show limited efficacy in some brain tumors.

Researchers have made important strides in understanding and treating diffuse midline gliomas, which were long seen as a ...

A form of glioma, a type of brain cancer, tends to progress toward greater malignancy due to an increasing tendency of glioma ...

Maternal cells that infiltrate children's brains during pregnancy take on different jobs in the brain and may persist into ...

A first-in-human cell therapy trial at Children's National produced four long-term survivors in children with terminal DIPG ...